ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

C.R. Bard 3Q Net Down 1.5% On Charges; Sales Fall Short

DOW JONES NEWSWIRES C.R. Bard Inc.'s (BCR) third-quarter profit fell 1.5% on acquisition and other charges as the medical-products maker reported revenue below analysts' expectations. The company--which makes vascular, urology and oncology devices--had seen profit and sales rebound in recent quarters as health-care spending has rebounded somewhat, although Americans have been cutting back on medical care lately. C.R. Bard posted earnings of $127.5 million, or $1.34 a share, compared with $129.5 million, or $1.31 a share, a year earlier. Shares outstanding fell 4% and the latest quarter included 9 cents of charges. Revenue rose 6.5% to $678.4 million and climbed 8% excluding currency fluctuations. Analysts, on average, expected earnings of $1.40 on revenue of $686.74 million. The company in July gave a mixed third-quarter forecast: earnings of $1.37 to $1.41 on revenue of $688 million to $701 million. Gross margin rose to a record 62.9% from 62.2%, but that was more than offset by overhead costs climbing 13%. The vascular business was Bard's biggest by revenue, and it climbed 13% on a constant currency basis. Similarly sized urology and vascular had lower growth. Shares of C.R. Bard closed Thursday at $85.14 and were inactive after-hours. -By Yogita Patel and Kevin Kingsbury, Dow Jones Newswires; 212-416-2262; yogita.patel@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
11/15/201308:47:28ValueAct Capital Management LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:18:57Farallon Capital Management 3Q 13F: Largest Eliminations
11/15/201308:18:52Farallon Capital Management 3Q 13F: Holdings As Of Sep 30
11/15/201307:07:30Two Sigma Investments 3Q 13F: Largest Eliminations
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Eliminations -2-
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Purchases
11/15/201307:07:27Two Sigma Investments 3Q 13F: Largest Sales
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Largest Purchases
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Holdings As Of -2-
11/15/201307:04:50Bridgewater Associates LP 3Q 13F: Largest -2-
11/15/201307:04:49Bridgewater Associates LP 3Q 13F: Holdings As Of Sep 30
09/04/201309:35:09U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
06/28/201310:54:22Boston Scientific to Buy C.R. Bard Unit for $275 Million
10/25/201218:32:16High-Grade-Bond Market Absorbs $3.9 Billion of New Deals
06/05/201212:53:24J&J to Stop Selling Surgical Mesh Amid Lawsuits, Concerns -AP
04/21/201200:20:37MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results
01/04/201216:13:14FDA Orders Post-Market Testing Of Surgical Mesh Amid Safety Concerns
12/21/201109:10:36US Stock Futures: HOT STOCKS TO WATCH
10/26/201107:57:35US Stock Futures Higher On Optimism Ahead Of EU Summit
09/14/201114:52:55Erste Group Bank To Buy 24.12% Stake In Romania Unit

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad